Detalhe da pesquisa
1.
The Status of Vaccine Development Against the Human Cytomegalovirus.
J Infect Dis
; 221(Suppl 1): S113-S122, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134478
2.
Development of a potent Zika virus vaccine using self-amplifying messenger RNA.
Sci Adv
; 6(32): eaba5068, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821824
3.
Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.
PLoS One
; 13(4): e0196311, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29694440
4.
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques.
Am J Trop Med Hyg
; 92(4): 698-708, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646261
5.
Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
AIDS Res Hum Retroviruses
; 20(4): 425-34, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15157361
6.
Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
Vaccine
; 32(23): 2756-62, 2014 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23867012
7.
Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice.
Vaccine
; 30(20): 3126-35, 2012 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22326899
8.
Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs.
Vaccine
; 30(37): 5557-63, 2012 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22727727
9.
Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
Expert Rev Vaccines
; 10(12): 1709-15, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22085174
10.
Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets.
Vaccine
; 29(11): 2092-9, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21237275
11.
Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
Vaccine
; 29(11): 2120-6, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21238573
12.
Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.
PLoS One
; 3(1): e1401, 2008 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18167560
13.
Cancer vaccines and immunotherapies: emerging perspectives.
Vaccine
; 23(17-18): 2359-62, 2005 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15755628
14.
Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.
Expert Opin Biol Ther
; 4(7): 1129-38, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15268679